01 1Teva Pharmaceutical Industries
01 1NAPROXEN SODIUM
01 1Israel
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2015-06-10
Pay. Date : 2015-05-28
DMF Number : 8746
Submission : 1990-09-18
Status : Active
Type : II
20
Tapi Nl Bv, based in Israel, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is NAPROXEN SODIUM, with a corresponding US DMF Number 8746.
Remarkably, this DMF maintains an Active status since its submission on September 18, 1990, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 10, 2015, and payment made on May 28, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II
